Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-08-004684
Filing Date
2008-06-09
Accepted
2008-06-09 17:11:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. g06286b2sv1za.htm S-1/A 1977051
2 EX-23.1 CONSENT OF KPMG LLP. g06286b2exv23w1.htm EX-23.1 2677
3 GRAPHIC g06286b2g0628602.gif GRAPHIC 3768
4 GRAPHIC g06286b2g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-08-004684.txt   1987045
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 08888811
SIC: 2834 Pharmaceutical Preparations